Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

AstraZeneca's new cysteine protease inhibitors claimed for COPD

Sep. 28, 2000

Merck Frosst describes efforts to obtain PDE4 inhibitors with improved properties

Sep. 27, 2000

Allergy researchers clarify IL-9-eosinophil interaction

Sep. 27, 2000

Positive results emerge from safety study with alpha1-antitrypsin in CF patients

Sep. 25, 2000

Fluticasone more effective than montelukast in asthma control

Sep. 22, 2000

Antex Pharma licenses new peptides to treat lung diseases

Sep. 22, 2000

AstraZeneca posts important revisions to Accolate label

Sep. 21, 2000

FDA approves QVAR Inhalation Aerosol for treatment of asthma

Sep. 20, 2000

Novel chemokine receptor modulators revealed by Millennium

Sep. 19, 2000

Serine protease inhibitors for asthma, pancreatitis designed by Ortho-McNeil scientists

Sep. 15, 2000

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...